SCHEMBL23970756

SCHEMBL23970756

CC(C)(C)OC(=O)c1ccncc1CCCCCO

nearest known ligand 0.36

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.36
KDM4E B2RXH2 1/20 0.35
ALDH1A1 P00352 1/20 0.35
GLA P06280 1/20 0.35
GAA P10253 1/20 0.35
CYP4F2 P78329 2/20 0.35
CYP4A11 Q02928 2/20 0.35
RXRA P19793 2/20 0.34
NR1H2 P55055 2/20 0.34
NR1H3 Q13133 1/20 0.34
CYP3A4 P08684 1/20 0.34
LATS1 O95835 6/20 0.34
LATS2 Q9NRM7 1/20 0.34
TBXAS1 P24557 5/20 0.33
ADRA1A P35348 1/20 0.33
ADRA1B P35368 1/20 0.33
EGFR P00533 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30159052 1.00 TDP1 (0.36) TDP1KDM4EALDH1A1GLAGAA
SCHEMBL23970754 0.90 TDP1 (0.36) TDP1KDM4EALDH1A1GLAGAA
SCHEMBL23970600 0.81 ALDH1A1 (0.43) TDP1ALDH1A1CYP4F2CYP4A11RXRA
SCHEMBL9720220 0.79 ALDH1A1 (0.44) TDP1ALDH1A1CYP4F2CYP4A11NR1H2
SCHEMBL23971329 0.77 TDP1 (0.38) TDP1GAACYP4F2CYP4A11RXRA
SCHEMBL30159135 0.76 TDP1 (0.36) TDP1KDM4EALDH1A1GLAGAA
SCHEMBL23970514 0.76 TDP1 (0.36) TDP1KDM4EALDH1A1GLAGAA
SCHEMBL23971066 0.75 TDP1 (0.35) TDP1KDM4EALDH1A1GLAGAA
SCHEMBL23971073 0.75 TDP1 (0.35) TDP1KDM4EALDH1A1GLAGAA
SCHEMBL23970516 0.74 TDP1 (0.38) TDP1ALDH1A1GAACYP4F2CYP4A11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115551862-B Macrocyclic inhibitors of peptidyl arginine deiminase 吉利德科学公司 2024-04-12 CN disclosed
US-20230002412-A1 INHIBITORS OF PEPTIDYLARGININE DEIMINASES GILEAD SCIENCES, INC. 2023-01-05 US disclosed
CN-115551862-A Macrocyclic inhibitors of peptidyl arginine deiminase 吉利德科学公司 2022-12-30 CN disclosed
WO-2021222353-A1 MACROCYCLIC INHIBITORS OF PEPTIDYLARGININE DEIMINASES GILEAD SCIENCES, INC. (US) 2021-11-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230002412-A1 INHIBITORS OF PEPTIDYLARGININE DEIMINASES PADI4, PADI2, PADI1 TDP1 199/4885KDM4E 936/4885ALDH1A1 2537/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.